Financing Drugs in South-East Asia - Report of the First Meeting of the WHO/SEARO Working Group on Drug Financing, Korat, Thailand, 26-28 November 1996 - Health Economics and Drugs Series No. 004
(1997; 72 pages) Ver el documento en el formato PDF
Índice de contenido
Abrir esta carpeta y ver su contenidoExecutive summary
Abrir esta carpeta y ver su contenido1. Introduction
Abrir esta carpeta y ver su contenido2. Country presentations on drug financing
Abrir esta carpeta y ver su contenido3. Korat provincial field visit
Abrir esta carpeta y ver su contenido4. Drug financing issues
Abrir esta carpeta y ver su contenido5. Country priorities for drug financing
Abrir esta carpeta y ver su contenido6. Priorities for work group action
Abrir esta carpeta y ver su contenido7. Conclusions and recommendations
Ver el documentoAnnex A. Agenda
Ver el documentoAnnex B. List of participants
Ver el documentoAnnex C. List of documents
Ver el documentoAnnex D. Message from Regional Director, WHO South-East Asia Region
Cerrar esta carpetaAnnex E. Evaluation of the meeting. Priorities for the Working Group
Ver el documento1. Evaluation of the meeting
Ver el documento2. Priorities for the next Working Group meeting
 

1. Evaluation of the meeting

1. Evaluation forms were filled out by all 10 participants plus 4 observers from the Thai Ministry of Public Health. Each topic covered at the meeting was evaluated on its usefulness (scores are: 4 = very useful, 3 = useful, 2 = not too useful, and 1 = useless), and time spent (scores are: 3 = too little time, 2 = about right, and 1 = too much time). The mean scores and standard deviation are shown below.

For the hotel, the satisfaction scores are:

5 = excellent, 4 = very good, 3 = good, 2 = fair, and 1 = poor.

Topic

Usefulness

Time spent

 

n

mean ± s.d.

n

mean ± s.d.

Tuesday

Country presentations (Thailand, Nepal, Myanmar)

14

3.21 ± 0.43

14

2.14 ± 0.53

Field visit to hospital

14

3.57 ± 0.51

14

2.21 ± .0.43

Field visit to health centre

11

3.55 ± 0.52

11

2.18 ± .0.40

Field visit to village drug fund

10

3.50 ± 0.53

10

2.20 ± .0.42

Wednesday

Discussion of field visit

13

3.23 ± 0.73

13

2.00 ± .0.58

Country presentation (Indonesia)

14

3.14 ± 0.36

14

2.21 ± .0.43

Drug financing strategies
(Dr Velasquez)

14

3.50 ± 0.52

14

2.21 ± .0.43

Cost-sharing for drugs
(Dr Petcharat)

14

3.57 ± 0.51

14

2.07 ± .0.27

Priorities for drug financing
(priorities for each country)

14

3.21 ± 0.58

14

2.21 ± .0.58

Monitoring for equity and quality
(Dr Quick)

14

3.64 ± 0.50

14

2.14 ± .0.53

Thursday

       

Priorities for drug financing (Group work)

14

3.43 ± 0.51

14

2.36 ± .0.50

Priorities for country action (Country group)

14

3.43 ± 0.51

14

2.36 ± .0.63

National health and drug financing indicators

14

3.50 ± 0.65

14

2.43 ± .0.65

Hotel

Satisfaction

   

Accommodation

14

3.93 ± 0.73

   

Food

14

3.79 ± 1.05

   

Meeting room

14

3.50 ± 0.85

   

2. Comments and suggestions on content and format of meeting:

• All right.

• Very good.

• Fine in format, but the agenda is too tight.

• 3-days meeting, 1 day field visit (2).

• 4-days workshops.

• Content and format very useful.

• For the next meeting, it would be better to invite an expert on public health with international experience.

• Too many subjects to be discussed, need more time.

• Content and format are appropriate to the subject of the meeting.

• Detailed information on the contents of the meeting should be given earlier.

3. Comments and suggestions on accommodation:

• Dinner should also have been provided in the hotel, eating places are not near by.
• Special food should be provided for Muslims.

4. Comments and suggestions on travel and other administrative arrangements:

• Not so bad.

• Financial difficulty. No money is provided to cover the hotel and other expenses here.

• The meeting should be held where there are good connections between international and domestic flights.

• WHO could provide a normal ticket for each participant to avoid difficulties.

• The ticket should be normal fare.

• Good.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013